Obesity

Life Science Podcast

The Neuroscience of Weight Regulation with Courage Therapeutics’ Dr. Roger Cone — Episode 221

Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies

October 07, 2025
Blogs

A Novel Approach to MASH Obesity Treatment: Weight Loss with Mitochondrial Science
Business & Finance News

Omada Health IPO Targets Musculoskeletal and Obesity Care with Digital-First Model
Biotech News

Novo Nordisk’s Amycretin Moves to Phase III: What Sets This Obesity Drug Apart?

Obesity Clinical Trials: Beyond BMI

July 23, 2025
Biotech Blogs

Innovative Science Driving New Approaches in Obesity Drug Development
Life Science Podcast

Tackling Cardiometabolic Disease Through Mitochondrial Science with Rivus Pharma’s Dr. Shaharyar Khan — Episode 205
Biotech Blogs

Harnessing the Body’s Natural Mechanisms: Aphaia Pharma’s Novel Approach to Metabolic Disease Treatment
Biotech Blogs

What’s the Latest Research in Weight Loss Medications Telling Us?

Beyond the Hype: Innovating Obesity Treatments for Real-World Impact

May 20, 2025
Biotech News

Roche Invests $5.3B in Zealand’s Petrelintide, an Obesity Drug Candidate
Biotech News

CagriSema, Novo Nordisk’s Latest Obesity Drug Offering, Disappoints Investors with Trial Results
Biotech News

Eli Lilly Cuts Price of Zepbound Vials and Introduces Higher-Dose Options
Business & Finance News

Aardvark Therapeutics IPO Sets Sights on Satiating Hyperphagia and Extreme Hunger
Biotech News

Obesity-Focused Metsera Launches IPO Amid Much Anticipation